Strontium [89Sr ] Chloride injection is used for palliative treatment of bone pain in patients with metastases from carcinomas of the prostatic gland and mammary gland. The most frequent indication for Strontium[89Sr ] Chloride therapy are multiple spread metastases in patients formerly treated with conventional therapeutic methods in which no pain relief response was obtained.
Nuclide data
T1/2 : 50.5d;
β- Energy : 1.495MeV
Technical parameter
Radionuclidic purity：＞99.9%
Radioactive concentration：≥37MBq/mL
Sr content：≤12.5mg/mL
Al content：≤2μg/ mL
pH: 4.0～7.5
Expiration: 30 days after production
Specifications
111MBq ；148MBq；222MBq；296MBq